<Record>
<Term>Yttrium Y 90 Monoclonal Antibody B3</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Radioimmunoconjugate</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioimmunoconjugate/Yttrium Y 90 Monoclonal Antibody B3</ClassificationPath>
<BroaderTerm>Yttrium Y 90 Monoclonal Antibody B3</BroaderTerm>
<BroaderTerm>Radioimmunoconjugate</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>90 Y-B3</Synonym>
<Synonym>MOAB B3, Yttrium Y 90</Synonym>
<Synonym>Y 90 Monoclonal Antibody B3</Synonym>
<Synonym>Y90-B3</Synonym>
<Synonym>Yttrium Y 90 Monoclonal Antibody B3</Synonym>
<Description>A radioimmunoconjugate of monoclonal antibody (MoAb) B3 conjugated with isotope yttrium 90. MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits beta particles that causes cytotoxicity in tumor cells and has both diagnostic and therapeutic uses.</Description>
<Source>NCI Thesaurus</Source>
</Record>
